Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
25 mai 2024 09h40 HE
|
Vera Therapeutics
72-week data consistent with disease modification in IgAN, selected as a best-ranked abstract;Rapid and sustained improvements in hematuria over 36 weeks, with resolution in significantly greater...
Science World’s Creative Technology Gallery Wins Prestigious CASC Award for Innovation, Leadership and Impact in Making Science Accessible
24 mai 2024 11h00 HE
|
Science World
Vancouver, BC, May 24, 2024 (GLOBE NEWSWIRE) -- Science World is pleased to share that its Creative Technology Gallery, co-presented by Beedie and RBC, has won an award at this year’s Canadian...
BioSenic fait le point sur ses activités du premier trimestre 2024
24 mai 2024 11h00 HE
|
BioSenic
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 24 mai 2024 à 17h00 CEST – BIOSENIC (Euronext Bruxelles et Paris : BIOS), la société en phase clinique spécialisée...
NANO Nuclear Energy Inc. to Present and Sponsors the Upcoming Augural ClimaTech 2024 in Boston, Massachusetts on June 3-5th, 2024
24 mai 2024 09h55 HE
|
NANO Nuclear Energy Inc.
NANO Nuclear’s Executives to speak on the Global Energy Transition and the Role of Nuclear New York, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO...
Finanstilsynets godkendelse af fusion af afdelinger under Investeringsforeningen Danske Invest
24 mai 2024 09h42 HE
|
Danske Invest
Med henvisning til børsmeddelelser af 13. marts 2024 og 23. april 2024 vedrørende den foreslåede fusion af afdelinger under Investeringsforeningen Danske Invest samt generalforsamlingens godkendelse...
Novotech annonce un protocole d’accord avec un centre de recherche expérimenté dans les psychédéliques lors de la 4e conférence annuelle sur le développement des thérapies et médicaments psychédéliques à Boston
23 mai 2024 23h22 HE
|
Novotech
BOSTON, 24 mai 2024 (GLOBE NEWSWIRE) -- Novotech le principal organisme de recherche sous contrat (Contract Research Organization, CRO) proposant des services complets à l’échelle mondiale et...
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
23 mai 2024 17h15 HE
|
Kronos Bio, Inc.
— KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed — — KB-0742 continues to show dose linear pharmacokinetics up to 80mg...
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
23 mai 2024 17h01 HE
|
HOOKIPA Pharma Inc.
HOOKIPA to present an oral abstract at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting on June 4Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile...
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
23 mai 2024 17h00 HE
|
Iovance Biotherapeutics, Inc.
Lifileucel TIL Cell Therapy in Combination with Pembrolizumab DemonstratesDeep, Durable Responses in Frontline Advanced Melanoma Patientsin IOV-COM-202 Clinical Study ASCO Oral Presentation to...
Introducing Dog WIF Seal: The Unexpected Darling of Solana's Crypto World
23 mai 2024 12h00 HE
|
Dog WIF Seal
Amsterdam, Netherlands , May 23, 2024 (GLOBE NEWSWIRE) -- In a surprising turn of events, the crypto community has been set ablaze with the emergence of an unlikely yet captivating project on the...